SCHEMBL560702

SCHEMBL560702

OC1CC/C=C/CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11913654 1.00
SCHEMBL560703 1.00
SCHEMBL21724830 1.00
SCHEMBL13858929 1.00
SCHEMBL868155 1.00
SCHEMBL15299654 1.00
SCHEMBL27285218 1.00
SCHEMBL10931150 0.97 TSHR (0.47)
SCHEMBL15130019 0.97 TSHR (0.47)
SCHEMBL9352358 0.97 TSHR (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 240 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12472267-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2025-11-18 US claimed
US-12390558-B2 Injection molding to generate complex hydrogel geometries for cell encapsulation ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2025-08-19 US claimed
US-20240384269-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSIOCHEMICAL CHARACTERISTICS Sixfold Bioscience Ltd. (GB) 2024-11-21 US claimed
EP-4323517-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS Sixfold Bioscience Ltd. (GB) 2024-02-21 EP claimed
EP-2922574-B1 CHEMICALLY CLEAVABLE GROUP TAGWORKS PHARMACEUTICALS B V (NL) 2023-05-17 EP claimed
CN-115997016-A Composition comprising nucleic acid nanoparticles having modular functional groups 西克斯福德生物科学有限公司 2023-04-21 CN claimed
EP-4143316-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2023-03-08 EP claimed
US-20220370635-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY SIXFOLD BIOSCIENCE LTD (GB) 2022-11-24 US claimed
WO-2022219409-A2 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES AND PROCESSES RELATED TO ALTERATION OF THEIR PHYSICOCHEMICAL CHARACTERISTICS Sixfold Bioscience Ltd. (GB) 2022-10-20 WO claimed
CN-114671851-A Naphthalimide-tetrazine compound and preparation method and application thereof 中国医学科学院药物研究所 2022-06-28 CN claimed
US-11357865-B2 Compositions containing nucleic acid nanoparticles with modular functionality Sixfold Bioscience Ltd. (GB) 2022-06-14 US claimed
US-20210330810-A1 COMPOSITIONS CONTAINING NUCLEIC ACID NANOPARTICLES WITH MODULAR FUNCTIONALITY Sixfold Bioscience Ltd. (GB) 2021-10-28 US claimed
US-10442789-B2 Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use SUTRO BIOPHARMA, INC. (US) 2019-10-15 US claimed
CN-122069828-A Solar cell, preparation method thereof and photovoltaic module 通威太阳能(成都)有限公司 2026-05-19 CN disclosed
US-20260021223-A1 HYDROGEL FILLERS FOR CONFORMABLE FILLABLE MEDICAL BALLOONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-01-22 US disclosed
US-20260020859-A1 MATERIALS FOR CONFORMABLE FILLABLE MEDICAL BALLOONS BOSTON SCIENTIFIC SCIMED, INC. (US) 2026-01-22 US disclosed
WO-2010119389-A2 PRETARGETING KIT, METHOD AND AGENTS USED THEREIN KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) 2010-10-21 WO disclosed
WO-2010051530-A2 COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET THE GENERAL HOSPITAL CORPORATION (US) 2010-05-06 WO disclosed
WO-2010051530-A2 COMPOSITIONS AND METHODS FOR DELIVERING A SUBSTANCE TO A BIOLOGICAL TARGET THE GENERAL HOSPITAL CORPORATION (US) 2010-05-06 WO disclosed
US-20090023916-A1 TETRAZINE-BASED BIO-ORTHOGONAL COUPLING REAGENTS AND METHODS UNIVERSITY OF DELAWARE (US) 2009-01-22 US disclosed